 Catherine Flaitz
Concepts (789)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 58 | 2017 | 154 | 4.570 |
Why?
| | Mouth Diseases | 21 | 2018 | 43 | 3.010 |
Why?
| | Mouth Neoplasms | 23 | 2012 | 84 | 2.220 |
Why?
| | Cariostatic Agents | 23 | 2014 | 30 | 2.100 |
Why?
| | Diagnosis, Differential | 60 | 2014 | 1429 | 2.000 |
Why?
| | Fluorides | 23 | 2014 | 50 | 1.890 |
Why?
| | Gingival Diseases | 12 | 2012 | 20 | 1.750 |
Why?
| | Dental Enamel | 32 | 2007 | 69 | 1.650 |
Why?
| | Mouth Mucosa | 21 | 2014 | 88 | 1.370 |
Why?
| | Tongue Neoplasms | 5 | 2013 | 24 | 1.360 |
Why?
| | Dental Restoration, Permanent | 12 | 2003 | 43 | 1.260 |
Why?
| | Mandibular Neoplasms | 13 | 2003 | 22 | 1.110 |
Why?
| | Precancerous Conditions | 6 | 2013 | 160 | 1.010 |
Why?
| | AIDS-Related Opportunistic Infections | 15 | 2005 | 123 | 0.970 |
Why?
| | Tooth, Deciduous | 12 | 2006 | 16 | 0.920 |
Why?
| | Carcinoma, Squamous Cell | 11 | 2013 | 625 | 0.920 |
Why?
| | Tooth Remineralization | 8 | 2007 | 12 | 0.920 |
Why?
| | Lip Diseases | 6 | 2013 | 7 | 0.920 |
Why?
| | Ethics, Dental | 3 | 2013 | 3 | 0.890 |
Why?
| | Mandibular Diseases | 7 | 2007 | 11 | 0.870 |
Why?
| | Pit and Fissure Sealants | 10 | 2007 | 19 | 0.870 |
Why?
| | Molar | 22 | 2014 | 49 | 0.870 |
Why?
| | Lichen Planus, Oral | 4 | 2013 | 6 | 0.870 |
Why?
| | HIV Infections | 31 | 2013 | 2721 | 0.730 |
Why?
| | Gingival Neoplasms | 5 | 2001 | 10 | 0.700 |
Why?
| | Humans | 228 | 2018 | 129144 | 0.700 |
Why?
| | Gingiva | 4 | 2012 | 25 | 0.660 |
Why?
| | Condylomata Acuminata | 3 | 2013 | 7 | 0.640 |
Why?
| | Composite Resins | 10 | 2010 | 109 | 0.610 |
Why?
| | Odontogenic Tumors | 6 | 2001 | 9 | 0.600 |
Why?
| | Glossitis | 3 | 2003 | 3 | 0.570 |
Why?
| | Burns, Chemical | 2 | 2012 | 29 | 0.560 |
Why?
| | Fluorides, Topical | 9 | 2004 | 13 | 0.540 |
Why?
| | Sarcoma, Kaposi | 8 | 2002 | 76 | 0.530 |
Why?
| | Drugs, Chinese Herbal | 1 | 2016 | 15 | 0.500 |
Why?
| | Resin Cements | 8 | 2010 | 28 | 0.490 |
Why?
| | Tongue | 7 | 2004 | 76 | 0.490 |
Why?
| | Male | 93 | 2017 | 63456 | 0.480 |
Why?
| | Candidiasis, Oral | 13 | 2007 | 17 | 0.480 |
Why?
| | Saliva | 8 | 2003 | 210 | 0.480 |
Why?
| | Laser Therapy | 12 | 2006 | 129 | 0.470 |
Why?
| | Maxillary Diseases | 4 | 2012 | 7 | 0.460 |
Why?
| | Child | 56 | 2018 | 20768 | 0.460 |
Why?
| | Radiography | 19 | 2007 | 794 | 0.460 |
Why?
| | Acidulated Phosphate Fluoride | 12 | 2007 | 12 | 0.450 |
Why?
| | Dental Sac | 1 | 2014 | 1 | 0.450 |
Why?
| | Gingival Hypertrophy | 1 | 2014 | 1 | 0.450 |
Why?
| | Dental Bonding | 6 | 2010 | 33 | 0.440 |
Why?
| | Analysis of Variance | 24 | 2007 | 1288 | 0.440 |
Why?
| | Root Caries | 9 | 2014 | 10 | 0.430 |
Why?
| | Mouth Floor | 4 | 2001 | 7 | 0.430 |
Why?
| | Herpesvirus 4, Human | 9 | 2007 | 156 | 0.430 |
Why?
| | Dental Plaque | 6 | 2004 | 17 | 0.430 |
Why?
| | Microscopy, Polarization | 17 | 2013 | 31 | 0.410 |
Why?
| | Granular Cell Tumor | 2 | 2003 | 7 | 0.410 |
Why?
| | Lasers | 7 | 2004 | 132 | 0.410 |
Why?
| | Carcinoma, Mucoepidermoid | 4 | 2000 | 16 | 0.400 |
Why?
| | Oral Ulcer | 8 | 2003 | 10 | 0.400 |
Why?
| | Glass Ionomer Cements | 6 | 2003 | 10 | 0.390 |
Why?
| | Salivary Gland Neoplasms | 4 | 2000 | 33 | 0.390 |
Why?
| | Odontogenic Cysts | 1 | 2012 | 1 | 0.390 |
Why?
| | Dentifrices | 3 | 2014 | 5 | 0.380 |
Why?
| | Purpura | 1 | 2012 | 14 | 0.380 |
Why?
| | Leukoplakia, Hairy | 8 | 2004 | 8 | 0.380 |
Why?
| | Head and Neck Neoplasms | 4 | 2002 | 542 | 0.370 |
Why?
| | Ethics, Professional | 1 | 2011 | 15 | 0.370 |
Why?
| | Jaw Diseases | 2 | 2005 | 4 | 0.370 |
Why?
| | Gingivitis | 2 | 2010 | 12 | 0.370 |
Why?
| | Tooth Diseases | 2 | 2001 | 13 | 0.360 |
Why?
| | Palatal Neoplasms | 2 | 2001 | 5 | 0.360 |
Why?
| | Gingival Hyperplasia | 1 | 2010 | 3 | 0.360 |
Why?
| | Child, Preschool | 32 | 2017 | 10456 | 0.350 |
Why?
| | Cheek | 2 | 2000 | 15 | 0.340 |
Why?
| | Dental Cavity Preparation | 7 | 2003 | 8 | 0.340 |
Why?
| | Gingivitis, Necrotizing Ulcerative | 5 | 2003 | 5 | 0.340 |
Why?
| | Female | 75 | 2017 | 68494 | 0.340 |
Why?
| | Sodium Fluoride | 8 | 2013 | 15 | 0.340 |
Why?
| | HIV Seropositivity | 4 | 2007 | 119 | 0.340 |
Why?
| | Lithiasis | 1 | 2009 | 3 | 0.330 |
Why?
| | Fibroma, Ossifying | 3 | 2001 | 3 | 0.330 |
Why?
| | Tooth Eruption | 5 | 2014 | 9 | 0.330 |
Why?
| | Pharyngeal Diseases | 1 | 2009 | 15 | 0.330 |
Why?
| | Schools, Dental | 2 | 2011 | 15 | 0.330 |
Why?
| | Leukoplakia, Oral | 3 | 2011 | 8 | 0.330 |
Why?
| | Palatine Tonsil | 1 | 2009 | 45 | 0.320 |
Why?
| | Adult | 55 | 2013 | 35469 | 0.320 |
Why?
| | Teaching | 1 | 2011 | 214 | 0.310 |
Why?
| | Academic Medical Centers | 2 | 2011 | 474 | 0.310 |
Why?
| | Cysts | 3 | 2002 | 108 | 0.310 |
Why?
| | Glossitis, Benign Migratory | 3 | 2010 | 5 | 0.300 |
Why?
| | Anesthesia, Dental | 5 | 2014 | 20 | 0.300 |
Why?
| | Immunocompromised Host | 6 | 2013 | 198 | 0.300 |
Why?
| | Alveolar Bone Loss | 2 | 2007 | 9 | 0.300 |
Why?
| | Stomatitis, Herpetic | 4 | 2001 | 5 | 0.290 |
Why?
| | Epithelium | 9 | 2012 | 311 | 0.290 |
Why?
| | Acyclovir | 6 | 2004 | 99 | 0.290 |
Why?
| | Salivary Gland Calculi | 2 | 2000 | 3 | 0.290 |
Why?
| | Histiocytosis, Langerhans-Cell | 2 | 2005 | 36 | 0.290 |
Why?
| | Dental Care for Chronically Ill | 5 | 2006 | 11 | 0.290 |
Why?
| | Middle Aged | 41 | 2013 | 31050 | 0.290 |
Why?
| | Dental Materials | 3 | 2003 | 56 | 0.290 |
Why?
| | Tooth Demineralization | 8 | 2013 | 10 | 0.280 |
Why?
| | Acquired Immunodeficiency Syndrome | 4 | 2001 | 227 | 0.280 |
Why?
| | Acid Etching, Dental | 7 | 2001 | 15 | 0.280 |
Why?
| | Cell Transformation, Neoplastic | 3 | 2011 | 326 | 0.280 |
Why?
| | Incisor | 4 | 2002 | 17 | 0.280 |
Why?
| | Papillomavirus Infections | 3 | 2013 | 296 | 0.280 |
Why?
| | Denture, Complete, Lower | 1 | 2007 | 1 | 0.270 |
Why?
| | Dental Implantation, Endosseous | 1 | 2007 | 2 | 0.270 |
Why?
| | Learning | 1 | 2011 | 401 | 0.270 |
Why?
| | Zirconium | 3 | 2001 | 8 | 0.270 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2007 | 6 | 0.270 |
Why?
| | Maxillary Neoplasms | 4 | 1995 | 8 | 0.270 |
Why?
| | Dental Implants | 1 | 2007 | 9 | 0.270 |
Why?
| | Gingival Overgrowth | 3 | 2003 | 5 | 0.270 |
Why?
| | Saliva, Artificial | 9 | 2014 | 11 | 0.260 |
Why?
| | Valine | 5 | 2004 | 81 | 0.260 |
Why?
| | Dentists | 3 | 2001 | 19 | 0.260 |
Why?
| | Tooth, Unerupted | 2 | 2002 | 2 | 0.260 |
Why?
| | Tooth, Impacted | 3 | 2003 | 8 | 0.260 |
Why?
| | Biopsy | 8 | 2012 | 1084 | 0.250 |
Why?
| | Texas | 8 | 2017 | 228 | 0.250 |
Why?
| | Dental Enamel Solubility | 5 | 2006 | 5 | 0.250 |
Why?
| | Maxilla | 7 | 2002 | 33 | 0.250 |
Why?
| | Silicon Dioxide | 3 | 2001 | 109 | 0.250 |
Why?
| | Epstein-Barr Virus Infections | 5 | 2007 | 95 | 0.250 |
Why?
| | Molluscum Contagiosum | 2 | 2002 | 2 | 0.240 |
Why?
| | Sarcoidosis | 1 | 2007 | 156 | 0.240 |
Why?
| | Dental Caries Susceptibility | 11 | 2006 | 11 | 0.240 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2005 | 5 | 0.240 |
Why?
| | Dental Research | 1 | 2005 | 4 | 0.240 |
Why?
| | Odontoma | 2 | 2003 | 4 | 0.240 |
Why?
| | Cytodiagnosis | 4 | 2012 | 32 | 0.230 |
Why?
| | Cuspid | 2 | 2002 | 11 | 0.230 |
Why?
| | Dentist-Patient Relations | 3 | 2013 | 5 | 0.230 |
Why?
| | Microscopy, Electron, Scanning | 15 | 2003 | 196 | 0.230 |
Why?
| | Blister | 2 | 2001 | 41 | 0.230 |
Why?
| | Tooth Root | 9 | 2013 | 13 | 0.230 |
Why?
| | Lymphocele | 1 | 2004 | 2 | 0.230 |
Why?
| | Compomers | 2 | 2003 | 2 | 0.230 |
Why?
| | Tongue Diseases | 1 | 2004 | 9 | 0.230 |
Why?
| | Mucocele | 2 | 2001 | 12 | 0.220 |
Why?
| | Hemangioma | 2 | 2002 | 44 | 0.220 |
Why?
| | Calcium Phosphates | 2 | 2004 | 23 | 0.220 |
Why?
| | Warts | 2 | 2001 | 5 | 0.220 |
Why?
| | Root Resorption | 3 | 2006 | 4 | 0.220 |
Why?
| | Lymphoma, AIDS-Related | 2 | 2002 | 14 | 0.220 |
Why?
| | Argon | 16 | 2004 | 21 | 0.220 |
Why?
| | Calcium | 5 | 2007 | 1211 | 0.210 |
Why?
| | Hyperplasia | 5 | 2003 | 171 | 0.210 |
Why?
| | Prognosis | 12 | 2002 | 3766 | 0.210 |
Why?
| | Lymphatic Diseases | 2 | 2002 | 21 | 0.210 |
Why?
| | Granuloma, Giant Cell | 2 | 2000 | 4 | 0.210 |
Why?
| | Erythema | 2 | 2001 | 28 | 0.210 |
Why?
| | Bites, Human | 2 | 2014 | 3 | 0.210 |
Why?
| | Cytomegalovirus Infections | 2 | 1996 | 189 | 0.210 |
Why?
| | Dental Amalgam | 1 | 2002 | 3 | 0.210 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 2002 | 5 | 0.200 |
Why?
| | Adolescent | 30 | 2014 | 20297 | 0.200 |
Why?
| | Universities | 1 | 2005 | 407 | 0.200 |
Why?
| | Parotitis | 2 | 2003 | 6 | 0.190 |
Why?
| | Germinal Center | 1 | 2002 | 57 | 0.190 |
Why?
| | Lip Neoplasms | 1 | 2002 | 2 | 0.190 |
Why?
| | Crowns | 1 | 2002 | 4 | 0.190 |
Why?
| | Disease Progression | 6 | 2013 | 2622 | 0.190 |
Why?
| | Cheilitis | 2 | 2003 | 3 | 0.190 |
Why?
| | Toothpastes | 2 | 2000 | 5 | 0.190 |
Why?
| | Personal Autonomy | 2 | 2013 | 48 | 0.190 |
Why?
| | Sublingual Gland | 1 | 2001 | 1 | 0.190 |
Why?
| | Sialadenitis | 1 | 2001 | 2 | 0.190 |
Why?
| | Cyclosporine | 1 | 2003 | 263 | 0.190 |
Why?
| | Salivary Glands, Minor | 2 | 2000 | 9 | 0.190 |
Why?
| | Nevus, Blue | 1 | 2001 | 2 | 0.190 |
Why?
| | Diazepam | 3 | 1986 | 34 | 0.190 |
Why?
| | Rhabdomyosarcoma | 1 | 2002 | 64 | 0.190 |
Why?
| | Light | 6 | 2012 | 359 | 0.190 |
Why?
| | Evidence-Based Dentistry | 2 | 2012 | 6 | 0.180 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2013 | 267 | 0.180 |
Why?
| | Fibroma | 1 | 2001 | 22 | 0.180 |
Why?
| | Pediatric Dentistry | 3 | 2001 | 11 | 0.180 |
Why?
| | Durapatite | 2 | 2004 | 34 | 0.180 |
Why?
| | Hair Dyes | 1 | 2000 | 2 | 0.180 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2001 | 71 | 0.180 |
Why?
| | Lip | 2 | 2000 | 21 | 0.180 |
Why?
| | Burkitt Lymphoma | 1 | 2001 | 56 | 0.180 |
Why?
| | Sjogren's Syndrome | 1 | 2001 | 48 | 0.180 |
Why?
| | Malpractice | 1 | 2001 | 38 | 0.180 |
Why?
| | Dental Care for Children | 2 | 1999 | 10 | 0.170 |
Why?
| | Candida | 4 | 2006 | 37 | 0.170 |
Why?
| | Resins, Synthetic | 1 | 2000 | 13 | 0.170 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 854 | 0.170 |
Why?
| | Palate, Hard | 1 | 2000 | 5 | 0.170 |
Why?
| | Sunlight | 1 | 2001 | 72 | 0.170 |
Why?
| | Neuroma | 1 | 2000 | 7 | 0.170 |
Why?
| | Neoplasms, Second Primary | 1 | 2002 | 106 | 0.170 |
Why?
| | Neoplasm Recurrence, Local | 7 | 2011 | 954 | 0.170 |
Why?
| | Focal Epithelial Hyperplasia | 1 | 2000 | 1 | 0.170 |
Why?
| | Lymphangioma | 1 | 2000 | 7 | 0.170 |
Why?
| | Calcinosis | 1 | 2002 | 231 | 0.170 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2000 | 35 | 0.170 |
Why?
| | Lipoma | 1 | 2000 | 15 | 0.170 |
Why?
| | Virus Replication | 6 | 2007 | 450 | 0.160 |
Why?
| | Herpesvirus 8, Human | 2 | 1997 | 60 | 0.160 |
Why?
| | Biomarkers, Tumor | 4 | 2004 | 1161 | 0.160 |
Why?
| | Mineral Waters | 2 | 1989 | 2 | 0.160 |
Why?
| | Mandible | 5 | 2007 | 61 | 0.160 |
Why?
| | Child Behavior | 3 | 2014 | 235 | 0.160 |
Why?
| | Candidiasis | 1 | 1999 | 56 | 0.160 |
Why?
| | Self-Injurious Behavior | 1 | 2000 | 120 | 0.160 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2014 | 541 | 0.160 |
Why?
| | Oncogenic Viruses | 1 | 1998 | 3 | 0.160 |
Why?
| | Vinblastine | 3 | 1995 | 70 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2001 | 176 | 0.150 |
Why?
| | Attitude to Health | 2 | 2013 | 430 | 0.150 |
Why?
| | Surface Properties | 8 | 2003 | 397 | 0.150 |
Why?
| | Facial Dermatoses | 3 | 2008 | 16 | 0.150 |
Why?
| | Statistics, Nonparametric | 7 | 2007 | 419 | 0.150 |
Why?
| | Dens in Dente | 2 | 1990 | 2 | 0.150 |
Why?
| | Recurrence | 6 | 2003 | 1005 | 0.150 |
Why?
| | Osteoradionecrosis | 1 | 1998 | 2 | 0.150 |
Why?
| | Nose Diseases | 1 | 1998 | 12 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1363 | 0.150 |
Why?
| | Pulpotomy | 2 | 1989 | 2 | 0.140 |
Why?
| | Myxoma | 1 | 1997 | 12 | 0.140 |
Why?
| | Palate | 1 | 1998 | 35 | 0.140 |
Why?
| | X-Ray Film | 2 | 1987 | 5 | 0.140 |
Why?
| | Specimen Handling | 1 | 1998 | 162 | 0.140 |
Why?
| | Cleft Lip | 1 | 2017 | 43 | 0.140 |
Why?
| | Periodontal Diseases | 3 | 2007 | 61 | 0.140 |
Why?
| | Bicuspid | 5 | 2001 | 17 | 0.130 |
Why?
| | Taste Buds | 1 | 1999 | 204 | 0.130 |
Why?
| | Cleft Palate | 1 | 2017 | 57 | 0.130 |
Why?
| | Dentin-Bonding Agents | 4 | 2003 | 17 | 0.130 |
Why?
| | Xylitol | 2 | 2014 | 3 | 0.130 |
Why?
| | Tooth Bleaching | 1 | 1996 | 3 | 0.130 |
Why?
| | Peroxides | 1 | 1996 | 19 | 0.130 |
Why?
| | Cooperative Behavior | 4 | 2011 | 433 | 0.130 |
Why?
| | Secondary Prevention | 3 | 2002 | 218 | 0.130 |
Why?
| | Ameloblastoma | 2 | 1993 | 5 | 0.130 |
Why?
| | Chronic Disease | 2 | 2018 | 1714 | 0.130 |
Why?
| | Acids | 2 | 2012 | 15 | 0.130 |
Why?
| | Melanoma | 2 | 2000 | 729 | 0.130 |
Why?
| | Ulcer | 1 | 1996 | 28 | 0.130 |
Why?
| | Urea | 1 | 1996 | 76 | 0.130 |
Why?
| | Anesthesia, Rectal | 2 | 1985 | 2 | 0.130 |
Why?
| | Langerhans Cells | 2 | 2007 | 11 | 0.130 |
Why?
| | HIV Seronegativity | 4 | 2007 | 25 | 0.120 |
Why?
| | Jaw Neoplasms | 1 | 1995 | 2 | 0.120 |
Why?
| | Acculturation | 1 | 2016 | 51 | 0.120 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 1995 | 6 | 0.120 |
Why?
| | Infant | 11 | 2002 | 8975 | 0.120 |
Why?
| | Statistics as Topic | 5 | 2001 | 305 | 0.120 |
Why?
| | Osteomyelitis | 2 | 2000 | 121 | 0.120 |
Why?
| | Age Factors | 6 | 2016 | 3140 | 0.120 |
Why?
| | Sex Factors | 4 | 2016 | 1964 | 0.120 |
Why?
| | Orthodontic Brackets | 3 | 2010 | 15 | 0.120 |
Why?
| | Phosphates | 4 | 2013 | 179 | 0.110 |
Why?
| | Tooth Eruption, Ectopic | 2 | 2003 | 2 | 0.110 |
Why?
| | Gingival Hemorrhage | 1 | 2014 | 2 | 0.110 |
Why?
| | Hernia | 1 | 2014 | 10 | 0.110 |
Why?
| | Apatites | 2 | 2004 | 4 | 0.110 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 3 | 2000 | 54 | 0.110 |
Why?
| | Risk Factors | 10 | 2018 | 9740 | 0.110 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 1995 | 187 | 0.110 |
Why?
| | Diastema | 1 | 1993 | 3 | 0.110 |
Why?
| | Fat Necrosis | 1 | 1993 | 8 | 0.110 |
Why?
| | Conscious Sedation | 1 | 2014 | 85 | 0.110 |
Why?
| | Tooth Abnormalities | 2 | 2001 | 12 | 0.110 |
Why?
| | Hypercalcemia | 1 | 1993 | 21 | 0.110 |
Why?
| | Skin Neoplasms | 1 | 2001 | 824 | 0.110 |
Why?
| | Papillomaviridae | 3 | 2000 | 113 | 0.110 |
Why?
| | Epithelial Cells | 4 | 2007 | 1064 | 0.110 |
Why?
| | Mass Screening | 2 | 2012 | 1148 | 0.110 |
Why?
| | Aurothioglucose | 1 | 1993 | 7 | 0.100 |
Why?
| | Chromosome Aberrations | 2 | 2005 | 147 | 0.100 |
Why?
| | Lichen Planus | 1 | 1993 | 3 | 0.100 |
Why?
| | Thermodynamics | 5 | 2001 | 406 | 0.100 |
Why?
| | Keratosis | 2 | 2003 | 16 | 0.100 |
Why?
| | Human papillomavirus 16 | 1 | 2013 | 34 | 0.100 |
Why?
| | Hypnotics and Sedatives | 1 | 2014 | 174 | 0.100 |
Why?
| | Low-Level Light Therapy | 2 | 2004 | 3 | 0.100 |
Why?
| | Antiviral Agents | 6 | 2004 | 712 | 0.100 |
Why?
| | Acrylic Resins | 3 | 2007 | 44 | 0.100 |
Why?
| | DMF Index | 5 | 2003 | 17 | 0.100 |
Why?
| | Curriculum | 2 | 2011 | 909 | 0.100 |
Why?
| | Cariogenic Agents | 2 | 2014 | 2 | 0.100 |
Why?
| | Tooth Erosion | 1 | 2012 | 3 | 0.100 |
Why?
| | Wound Healing | 2 | 2005 | 305 | 0.100 |
Why?
| | Candy | 1 | 2012 | 4 | 0.100 |
Why?
| | Adolescent Behavior | 2 | 2002 | 506 | 0.090 |
Why?
| | Dentin | 5 | 2001 | 23 | 0.090 |
Why?
| | Moral Development | 1 | 2011 | 2 | 0.090 |
Why?
| | Schools, Health Occupations | 1 | 2011 | 6 | 0.090 |
Why?
| | Simplexvirus | 3 | 1998 | 80 | 0.090 |
Why?
| | Dental Hygienists | 1 | 2011 | 11 | 0.090 |
Why?
| | Administrative Personnel | 1 | 2011 | 28 | 0.090 |
Why?
| | Bioethical Issues | 1 | 2011 | 8 | 0.090 |
Why?
| | Keratins | 1 | 2012 | 175 | 0.090 |
Why?
| | Aged | 13 | 2012 | 21997 | 0.090 |
Why?
| | Organizational Objectives | 1 | 2011 | 73 | 0.090 |
Why?
| | Dental Cavity Lining | 2 | 2002 | 2 | 0.090 |
Why?
| | General Practice, Dental | 3 | 2006 | 5 | 0.090 |
Why?
| | Dental Alloys | 3 | 2002 | 5 | 0.090 |
Why?
| | Staff Development | 1 | 2011 | 55 | 0.090 |
Why?
| | Truth Disclosure | 1 | 2011 | 44 | 0.090 |
Why?
| | Alphapapillomavirus | 1 | 2011 | 39 | 0.090 |
Why?
| | Stomatitis, Aphthous | 2 | 2001 | 10 | 0.090 |
Why?
| | Granuloma, Pyogenic | 2 | 2001 | 7 | 0.090 |
Why?
| | Immunohistochemistry | 5 | 2003 | 1678 | 0.090 |
Why?
| | Professional Competence | 1 | 2011 | 94 | 0.090 |
Why?
| | Problem-Based Learning | 1 | 2011 | 78 | 0.090 |
Why?
| | DNA, Viral | 5 | 2004 | 347 | 0.090 |
Why?
| | Quality of Life | 2 | 2013 | 2680 | 0.090 |
Why?
| | Medical History Taking | 1 | 1991 | 118 | 0.090 |
Why?
| | Organizational Innovation | 1 | 2011 | 139 | 0.090 |
Why?
| | Polyvinyls | 2 | 2007 | 18 | 0.090 |
Why?
| | Orthodontic Appliances | 2 | 2001 | 11 | 0.090 |
Why?
| | Faculty | 1 | 2011 | 136 | 0.080 |
Why?
| | HIV-1 | 1 | 1996 | 837 | 0.080 |
Why?
| | Formocresols | 2 | 1989 | 2 | 0.080 |
Why?
| | Gingival Recession | 2 | 2007 | 6 | 0.080 |
Why?
| | Choice Behavior | 1 | 2011 | 164 | 0.080 |
Why?
| | Collagen | 1 | 2012 | 433 | 0.080 |
Why?
| | Periapical Diseases | 1 | 1989 | 1 | 0.080 |
Why?
| | Pulpectomy | 1 | 1989 | 1 | 0.080 |
Why?
| | Parents | 2 | 2016 | 1308 | 0.080 |
Why?
| | Dental Clinics | 2 | 2001 | 5 | 0.080 |
Why?
| | Program Development | 1 | 2011 | 355 | 0.080 |
Why?
| | Tin Fluorides | 2 | 1988 | 3 | 0.080 |
Why?
| | Gels | 3 | 2014 | 81 | 0.080 |
Why?
| | Cell Division | 3 | 2000 | 796 | 0.080 |
Why?
| | Infant, Newborn | 7 | 2002 | 5736 | 0.080 |
Why?
| | Water Supply | 1 | 1989 | 74 | 0.080 |
Why?
| | Follow-Up Studies | 6 | 2014 | 4882 | 0.070 |
Why?
| | Proliferating Cell Nuclear Antigen | 2 | 2000 | 53 | 0.070 |
Why?
| | Hamartoma | 1 | 2008 | 20 | 0.070 |
Why?
| | Nevus | 1 | 2008 | 24 | 0.070 |
Why?
| | Drug Combinations | 2 | 2001 | 330 | 0.070 |
Why?
| | Photomicrography | 2 | 2000 | 7 | 0.070 |
Why?
| | CD4 Lymphocyte Count | 4 | 2006 | 266 | 0.070 |
Why?
| | Vaccination | 1 | 1996 | 1347 | 0.070 |
Why?
| | Porosity | 3 | 2003 | 92 | 0.070 |
Why?
| | Xerostomia | 3 | 2000 | 17 | 0.070 |
Why?
| | Radicular Cyst | 2 | 1998 | 2 | 0.070 |
Why?
| | In Vitro Techniques | 5 | 2002 | 1085 | 0.070 |
Why?
| | Dental Restoration Failure | 2 | 2006 | 6 | 0.070 |
Why?
| | Viral Matrix Proteins | 3 | 2004 | 29 | 0.070 |
Why?
| | Denture, Overlay | 1 | 2007 | 6 | 0.070 |
Why?
| | Jaw, Edentulous | 1 | 2007 | 7 | 0.070 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2000 | 70 | 0.070 |
Why?
| | Prevalence | 6 | 2001 | 2554 | 0.070 |
Why?
| | Denture Bases | 1 | 2006 | 1 | 0.070 |
Why?
| | Denture, Complete, Upper | 1 | 2006 | 2 | 0.070 |
Why?
| | Chromium Alloys | 1 | 2006 | 5 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 1988 | 275 | 0.070 |
Why?
| | Tooth Mobility | 2 | 2006 | 6 | 0.070 |
Why?
| | Osseointegration | 1 | 2007 | 56 | 0.070 |
Why?
| | Dental Prophylaxis | 2 | 2003 | 6 | 0.070 |
Why?
| | HIV | 3 | 1998 | 227 | 0.070 |
Why?
| | Dental Cements | 2 | 2002 | 20 | 0.070 |
Why?
| | Prospective Studies | 6 | 2014 | 7117 | 0.060 |
Why?
| | Practice Patterns, Dentists' | 1 | 2006 | 3 | 0.060 |
Why?
| | Root Canal Therapy | 1 | 2006 | 6 | 0.060 |
Why?
| | Root Canal Irrigants | 1 | 1986 | 3 | 0.060 |
Why?
| | Insurance Claim Reporting | 1 | 2006 | 22 | 0.060 |
Why?
| | Patient Education as Topic | 1 | 2011 | 737 | 0.060 |
Why?
| | Antigens, CD | 2 | 2002 | 487 | 0.060 |
Why?
| | Silicon | 1 | 2005 | 14 | 0.060 |
Why?
| | Education, Dental | 1 | 2006 | 27 | 0.060 |
Why?
| | Implants, Experimental | 1 | 2005 | 19 | 0.060 |
Why?
| | Neoplasm Staging | 4 | 2010 | 1280 | 0.060 |
Why?
| | Glass | 1 | 2005 | 43 | 0.060 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2005 | 15 | 0.060 |
Why?
| | Resins, Plant | 2 | 2002 | 4 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 992 | 0.060 |
Why?
| | Denture Design | 2 | 2006 | 4 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 58 | 0.060 |
Why?
| | Biomedical and Dental Materials | 1 | 2005 | 1 | 0.060 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2000 | 170 | 0.060 |
Why?
| | Molar, Third | 1 | 1985 | 6 | 0.060 |
Why?
| | Cytoplasmic Granules | 1 | 2005 | 78 | 0.060 |
Why?
| | Antifungal Agents | 3 | 2005 | 129 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2017 | 3372 | 0.060 |
Why?
| | Denture, Complete | 1 | 2005 | 4 | 0.060 |
Why?
| | Pathology, Oral | 1 | 2005 | 1 | 0.060 |
Why?
| | Ganciclovir | 2 | 1996 | 52 | 0.060 |
Why?
| | Treatment Outcome | 6 | 2007 | 10192 | 0.060 |
Why?
| | Romania | 2 | 2003 | 12 | 0.060 |
Why?
| | Malocclusion | 2 | 2001 | 25 | 0.060 |
Why?
| | Dental Cementum | 2 | 1995 | 5 | 0.060 |
Why?
| | Dental Pulp Necrosis | 2 | 2001 | 2 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2004 | 33 | 0.060 |
Why?
| | Phosphoric Acids | 4 | 2001 | 17 | 0.060 |
Why?
| | Receptors, CCR5 | 1 | 2004 | 57 | 0.060 |
Why?
| | Vocabulary, Controlled | 1 | 2005 | 45 | 0.060 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 10 | 0.060 |
Why?
| | Burning Mouth Syndrome | 2 | 1996 | 5 | 0.060 |
Why?
| | Osteosarcoma | 2 | 1998 | 70 | 0.060 |
Why?
| | Mental Recall | 1 | 1986 | 191 | 0.060 |
Why?
| | Retrospective Studies | 8 | 2017 | 14450 | 0.060 |
Why?
| | Dental Enamel Permeability | 1 | 2004 | 1 | 0.060 |
Why?
| | Lymphocytes | 2 | 2004 | 378 | 0.060 |
Why?
| | Halitosis | 1 | 2003 | 1 | 0.050 |
Why?
| | Neoplasm Invasiveness | 3 | 2000 | 481 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 90 | 0.050 |
Why?
| | History, 20th Century | 1 | 2005 | 291 | 0.050 |
Why?
| | Memory | 1 | 1986 | 255 | 0.050 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2004 | 740 | 0.050 |
Why?
| | Sex Distribution | 2 | 2002 | 359 | 0.050 |
Why?
| | Acetates | 2 | 2001 | 100 | 0.050 |
Why?
| | Fatal Outcome | 2 | 2002 | 299 | 0.050 |
Why?
| | Lymphoma, B-Cell | 1 | 2004 | 105 | 0.050 |
Why?
| | Connexins | 1 | 2003 | 51 | 0.050 |
Why?
| | Lactobacillus | 1 | 2003 | 26 | 0.050 |
Why?
| | Streptococcus mutans | 1 | 2003 | 8 | 0.050 |
Why?
| | Diet, Cariogenic | 1 | 2003 | 1 | 0.050 |
Why?
| | Secretory Rate | 1 | 2003 | 18 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2003 | 56 | 0.050 |
Why?
| | Materials Testing | 4 | 2013 | 342 | 0.050 |
Why?
| | Dental Leakage | 1 | 2002 | 3 | 0.050 |
Why?
| | Mentors | 1 | 2005 | 177 | 0.050 |
Why?
| | Methacrylates | 2 | 2000 | 112 | 0.050 |
Why?
| | Reed-Sternberg Cells | 1 | 2002 | 3 | 0.050 |
Why?
| | Factor XIIa | 1 | 2002 | 2 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2011 | 1065 | 0.050 |
Why?
| | Tooth Injuries | 2 | 2018 | 4 | 0.050 |
Why?
| | S100 Proteins | 1 | 2002 | 36 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2003 | 110 | 0.050 |
Why?
| | Mouthwashes | 3 | 2010 | 14 | 0.050 |
Why?
| | Polymerase Chain Reaction | 4 | 2003 | 1033 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 574 | 0.050 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2002 | 59 | 0.050 |
Why?
| | Lymphoma, Follicular | 1 | 2002 | 38 | 0.050 |
Why?
| | Remission Induction | 1 | 2003 | 271 | 0.050 |
Why?
| | Gold Alloys | 1 | 2002 | 1 | 0.050 |
Why?
| | Decision Trees | 1 | 2002 | 90 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2004 | 1198 | 0.050 |
Why?
| | Cleidocranial Dysplasia | 1 | 2001 | 1 | 0.050 |
Why?
| | Sclerosis | 1 | 2001 | 12 | 0.050 |
Why?
| | Cosmetic Techniques | 1 | 2002 | 20 | 0.050 |
Why?
| | Dental Service, Hospital | 1 | 2001 | 1 | 0.050 |
Why?
| | Skin Diseases | 1 | 2003 | 143 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2005 | 388 | 0.050 |
Why?
| | Respiratory System Abnormalities | 1 | 2001 | 16 | 0.050 |
Why?
| | Heart | 1 | 1985 | 637 | 0.050 |
Why?
| | Lactic Acid | 2 | 2014 | 298 | 0.050 |
Why?
| | Microfilament Proteins | 1 | 2002 | 126 | 0.050 |
Why?
| | Pericoronitis | 1 | 2001 | 1 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2003 | 317 | 0.050 |
Why?
| | Caustics | 1 | 2001 | 7 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 309 | 0.050 |
Why?
| | Hypoparathyroidism | 1 | 1981 | 4 | 0.050 |
Why?
| | 2-Propanol | 1 | 2001 | 22 | 0.050 |
Why?
| | Dental Enamel Hypoplasia | 1 | 1981 | 6 | 0.050 |
Why?
| | Carcinoma, Verrucous | 1 | 2001 | 2 | 0.050 |
Why?
| | Dental High-Speed Equipment | 1 | 2001 | 1 | 0.050 |
Why?
| | Facial Neoplasms | 1 | 2001 | 18 | 0.050 |
Why?
| | Diet | 1 | 1989 | 1212 | 0.050 |
Why?
| | Fishes | 1 | 2001 | 94 | 0.050 |
Why?
| | Anti-Infective Agents, Local | 1 | 2001 | 42 | 0.050 |
Why?
| | alpha 1-Antitrypsin | 1 | 2002 | 107 | 0.050 |
Why?
| | Salivary Gland Diseases | 1 | 2001 | 2 | 0.050 |
Why?
| | Time Factors | 8 | 2014 | 6541 | 0.050 |
Why?
| | AIDS Serodiagnosis | 1 | 2001 | 23 | 0.040 |
Why?
| | Mandibular Nerve | 1 | 2000 | 4 | 0.040 |
Why?
| | Plasminogen | 1 | 2001 | 31 | 0.040 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1989 | 1276 | 0.040 |
Why?
| | Melanocytes | 1 | 2001 | 64 | 0.040 |
Why?
| | Folliculitis | 1 | 2000 | 1 | 0.040 |
Why?
| | Alcohol Drinking | 4 | 2012 | 763 | 0.040 |
Why?
| | Tooth Crown | 1 | 2000 | 2 | 0.040 |
Why?
| | Liability, Legal | 1 | 2001 | 40 | 0.040 |
Why?
| | Silicates | 1 | 2000 | 15 | 0.040 |
Why?
| | Denture, Partial, Removable | 1 | 2000 | 2 | 0.040 |
Why?
| | Nickel | 2 | 2006 | 54 | 0.040 |
Why?
| | Hodgkin Disease | 1 | 2002 | 134 | 0.040 |
Why?
| | Phenols | 1 | 2001 | 96 | 0.040 |
Why?
| | Habits | 1 | 2000 | 43 | 0.040 |
Why?
| | Emergencies | 1 | 2001 | 155 | 0.040 |
Why?
| | Arthritis, Juvenile | 1 | 2001 | 53 | 0.040 |
Why?
| | Periodontitis | 1 | 2001 | 49 | 0.040 |
Why?
| | Polymethacrylic Acids | 1 | 2000 | 62 | 0.040 |
Why?
| | Diffusion | 1 | 2000 | 116 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 108 | 0.040 |
Why?
| | Silicic Acid | 1 | 2000 | 2 | 0.040 |
Why?
| | Carcinoma, Basal Cell | 1 | 2001 | 74 | 0.040 |
Why?
| | Coloring Agents | 3 | 2012 | 77 | 0.040 |
Why?
| | Hair | 1 | 2000 | 73 | 0.040 |
Why?
| | Smoking | 4 | 2012 | 1499 | 0.040 |
Why?
| | Complex Mixtures | 1 | 2000 | 11 | 0.040 |
Why?
| | Triclosan | 1 | 2000 | 9 | 0.040 |
Why?
| | Hyperpigmentation | 1 | 2000 | 25 | 0.040 |
Why?
| | Cytomegalovirus | 2 | 1998 | 154 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 157 | 0.040 |
Why?
| | Age Distribution | 3 | 2001 | 372 | 0.040 |
Why?
| | Nerve Block | 1 | 2000 | 65 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 317 | 0.040 |
Why?
| | Survival Rate | 2 | 2002 | 1869 | 0.040 |
Why?
| | Polymers | 2 | 2000 | 477 | 0.040 |
Why?
| | American Dental Association | 2 | 2012 | 6 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1722 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2000 | 100 | 0.040 |
Why?
| | Flavonoids | 1 | 1999 | 77 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 598 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 419 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2007 | 1888 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2003 | 423 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1998 | 7 | 0.040 |
Why?
| | Collagenases | 1 | 1998 | 23 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2004 | 776 | 0.040 |
Why?
| | Vacuum | 1 | 1998 | 18 | 0.040 |
Why?
| | Herpesviridae | 1 | 1998 | 22 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1998 | 29 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 181 | 0.040 |
Why?
| | Injections, Intralesional | 2 | 1995 | 33 | 0.040 |
Why?
| | Gram-Negative Anaerobic Cocci | 1 | 1998 | 1 | 0.040 |
Why?
| | Evaluation Studies as Topic | 2 | 1989 | 173 | 0.040 |
Why?
| | Suction | 1 | 1998 | 32 | 0.040 |
Why?
| | Virus Shedding | 1 | 1998 | 48 | 0.040 |
Why?
| | Equipment Design | 1 | 2000 | 512 | 0.040 |
Why?
| | Carrier Proteins | 1 | 2002 | 742 | 0.040 |
Why?
| | Bone Cysts | 1 | 1998 | 9 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 265 | 0.040 |
Why?
| | Fibrosarcoma | 1 | 1998 | 21 | 0.040 |
Why?
| | Periodontal Cyst | 1 | 1997 | 1 | 0.040 |
Why?
| | Eosinophilic Granuloma | 1 | 1997 | 3 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 1999 | 190 | 0.040 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1998 | 45 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 311 | 0.040 |
Why?
| | Nose | 1 | 1998 | 63 | 0.040 |
Why?
| | Incidence | 2 | 2012 | 2635 | 0.040 |
Why?
| | Motor Skills | 1 | 1998 | 92 | 0.040 |
Why?
| | Oropharyngeal Neoplasms | 1 | 1998 | 48 | 0.040 |
Why?
| | Temperature | 1 | 2000 | 635 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 522 | 0.030 |
Why?
| | Cytokines | 1 | 2005 | 2012 | 0.030 |
Why?
| | Survival Analysis | 1 | 2000 | 1268 | 0.030 |
Why?
| | Colony Count, Microbial | 3 | 2006 | 117 | 0.030 |
Why?
| | Radiotherapy | 1 | 1998 | 185 | 0.030 |
Why?
| | Herpes Zoster | 1 | 2001 | 317 | 0.030 |
Why?
| | Periapical Granuloma | 1 | 1996 | 1 | 0.030 |
Why?
| | Early Detection of Cancer | 2 | 2012 | 369 | 0.030 |
Why?
| | United States | 5 | 2012 | 13825 | 0.030 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2835 | 0.030 |
Why?
| | Cryptococcosis | 1 | 1997 | 26 | 0.030 |
Why?
| | Anti-HIV Agents | 2 | 2000 | 754 | 0.030 |
Why?
| | Dental Enamel Proteins | 1 | 1996 | 2 | 0.030 |
Why?
| | Role | 1 | 1996 | 31 | 0.030 |
Why?
| | Kidney Transplantation | 1 | 2003 | 670 | 0.030 |
Why?
| | Viral Proteins | 3 | 2004 | 327 | 0.030 |
Why?
| | Digestive System | 1 | 1996 | 29 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1996 | 14 | 0.030 |
Why?
| | Growth Substances | 1 | 1996 | 150 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 21 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1997 | 101 | 0.030 |
Why?
| | Tooth Extraction | 2 | 2001 | 23 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 827 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1613 | 0.030 |
Why?
| | Sarcoma, Small Cell | 1 | 1995 | 1 | 0.030 |
Why?
| | Carcinoma, Basosquamous | 1 | 1995 | 2 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2001 | 726 | 0.030 |
Why?
| | Placebos | 2 | 1986 | 201 | 0.030 |
Why?
| | Pilot Projects | 3 | 2006 | 1583 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1995 | 45 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2000 | 7037 | 0.030 |
Why?
| | Emergency Medical Services | 1 | 2001 | 521 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1996 | 169 | 0.030 |
Why?
| | Virus Activation | 2 | 2007 | 88 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 600 | 0.030 |
Why?
| | Cocarcinogenesis | 1 | 1995 | 14 | 0.030 |
Why?
| | Virus Latency | 2 | 2007 | 84 | 0.030 |
Why?
| | Immunization Schedule | 1 | 1996 | 197 | 0.030 |
Why?
| | Hydroxyzine | 1 | 2014 | 3 | 0.030 |
Why?
| | Meperidine | 1 | 2014 | 3 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 2014 | 12 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 29 | 0.030 |
Why?
| | Akathisia, Drug-Induced | 1 | 2014 | 6 | 0.030 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2014 | 12 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2056 | 0.030 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1994 | 8 | 0.030 |
Why?
| | Clobetasol | 1 | 1994 | 7 | 0.030 |
Why?
| | Sleep Stages | 1 | 2014 | 45 | 0.030 |
Why?
| | Genes, Viral | 2 | 2004 | 82 | 0.030 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1995 | 55 | 0.030 |
Why?
| | Midazolam | 1 | 2014 | 53 | 0.030 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2014 | 22 | 0.030 |
Why?
| | Adhesiveness | 1 | 1994 | 19 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2014 | 64 | 0.030 |
Why?
| | Ketoconazole | 1 | 1993 | 4 | 0.030 |
Why?
| | Salivary Proteins and Peptides | 1 | 1993 | 13 | 0.030 |
Why?
| | Vomiting | 1 | 2014 | 128 | 0.030 |
Why?
| | Awareness | 1 | 2014 | 99 | 0.030 |
Why?
| | Papillon-Lefevre Disease | 1 | 1993 | 1 | 0.030 |
Why?
| | Zidovudine | 1 | 1993 | 78 | 0.030 |
Why?
| | Surface-Active Agents | 1 | 2014 | 84 | 0.030 |
Why?
| | Receptor, ErbB-2 | 1 | 1995 | 325 | 0.030 |
Why?
| | Tooth Loss | 1 | 1993 | 26 | 0.030 |
Why?
| | Tolonium Chloride | 1 | 2012 | 3 | 0.020 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1991 | 4 | 0.020 |
Why?
| | Bacteria | 1 | 1998 | 813 | 0.020 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 112 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2012 | 84 | 0.020 |
Why?
| | Control Groups | 1 | 2011 | 11 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2011 | 27 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1995 | 507 | 0.020 |
Why?
| | Dental Marginal Adaptation | 2 | 2003 | 11 | 0.020 |
Why?
| | Triamcinolone Acetonide | 1 | 1991 | 27 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1986 | 1874 | 0.020 |
Why?
| | Antigens, Neoplasm | 1 | 1993 | 308 | 0.020 |
Why?
| | Physical Examination | 1 | 2012 | 234 | 0.020 |
Why?
| | Sarcoma, Ewing | 1 | 1991 | 87 | 0.020 |
Why?
| | RNA, Viral | 2 | 2004 | 619 | 0.020 |
Why?
| | Bias | 1 | 2011 | 196 | 0.020 |
Why?
| | Animals | 5 | 2005 | 35286 | 0.020 |
Why?
| | Review Literature as Topic | 1 | 2010 | 66 | 0.020 |
Why?
| | Cell Adhesion | 2 | 2006 | 452 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 675 | 0.020 |
Why?
| | Zinc Oxide-Eugenol Cement | 1 | 1989 | 2 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2008 | 0.020 |
Why?
| | Genotype | 2 | 2004 | 1833 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 1999 | 119 | 0.020 |
Why?
| | Sleep | 1 | 2014 | 684 | 0.020 |
Why?
| | Oral Hemorrhage | 2 | 2001 | 3 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 1998 | 426 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1988 | 39 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 212 | 0.020 |
Why?
| | Mice, Nude | 2 | 1999 | 682 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 5044 | 0.020 |
Why?
| | Prosthodontics | 1 | 2006 | 1 | 0.020 |
Why?
| | Endodontics | 1 | 2006 | 3 | 0.020 |
Why?
| | Dentistry, Operative | 1 | 2006 | 4 | 0.020 |
Why?
| | Periodontics | 1 | 2006 | 5 | 0.020 |
Why?
| | Dental Fistula | 1 | 2006 | 1 | 0.020 |
Why?
| | Periapical Periodontitis | 1 | 2006 | 2 | 0.020 |
Why?
| | Fluorescent Dyes | 2 | 1998 | 312 | 0.020 |
Why?
| | Current Procedural Terminology | 1 | 2006 | 12 | 0.020 |
Why?
| | Suppositories | 1 | 1986 | 3 | 0.020 |
Why?
| | Preanesthetic Medication | 1 | 1986 | 3 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 1554 | 0.020 |
Why?
| | Flow Cytometry | 3 | 1995 | 1155 | 0.020 |
Why?
| | Cohort Studies | 2 | 2011 | 5408 | 0.020 |
Why?
| | Anesthesia, Local | 1 | 1986 | 16 | 0.020 |
Why?
| | Amnesia | 1 | 1986 | 43 | 0.020 |
Why?
| | Pharmaceutical Preparations | 1 | 1988 | 171 | 0.020 |
Why?
| | Lung Neoplasms | 2 | 1995 | 2340 | 0.020 |
Why?
| | Beryllium | 1 | 2006 | 152 | 0.020 |
Why?
| | Drug Carriers | 1 | 2006 | 119 | 0.010 |
Why?
| | Diagnosis, Oral | 1 | 2005 | 6 | 0.010 |
Why?
| | Tissue Distribution | 1 | 2005 | 315 | 0.010 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 996 | 0.010 |
Why?
| | Immunoglobulin J-Chains | 1 | 2004 | 6 | 0.010 |
Why?
| | Lighting | 1 | 2004 | 24 | 0.010 |
Why?
| | Genes, Immunoglobulin | 1 | 2004 | 28 | 0.010 |
Why?
| | Wettability | 1 | 2004 | 13 | 0.010 |
Why?
| | Sequence Analysis | 1 | 2004 | 37 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 1997 | 2003 | 0.010 |
Why?
| | In Situ Hybridization | 2 | 1996 | 296 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 4075 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 80 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1496 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 777 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2004 | 63 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 262 | 0.010 |
Why?
| | Connexin 26 | 1 | 2003 | 8 | 0.010 |
Why?
| | Sulfur Compounds | 1 | 2003 | 7 | 0.010 |
Why?
| | Dental Plaque Index | 1 | 2003 | 4 | 0.010 |
Why?
| | Mouth | 1 | 2004 | 84 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 332 | 0.010 |
Why?
| | Periodontal Index | 1 | 2003 | 13 | 0.010 |
Why?
| | Orthodontic Wires | 1 | 2003 | 6 | 0.010 |
Why?
| | Tooth Movement Techniques | 1 | 2003 | 12 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2004 | 148 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 336 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 311 | 0.010 |
Why?
| | Breath Tests | 1 | 2003 | 87 | 0.010 |
Why?
| | Asthma | 1 | 1997 | 2219 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2004 | 2699 | 0.010 |
Why?
| | Adhesives | 1 | 2003 | 13 | 0.010 |
Why?
| | Longitudinal Studies | 2 | 2000 | 2716 | 0.010 |
Why?
| | Observer Variation | 1 | 2003 | 314 | 0.010 |
Why?
| | Colorado | 2 | 1990 | 4402 | 0.010 |
Why?
| | Herpes Simplex | 1 | 2003 | 92 | 0.010 |
Why?
| | Stomatitis | 1 | 2002 | 14 | 0.010 |
Why?
| | Pigmentation Disorders | 1 | 2002 | 9 | 0.010 |
Why?
| | Cell Movement | 1 | 2007 | 944 | 0.010 |
Why?
| | Color | 1 | 2002 | 73 | 0.010 |
Why?
| | Tooth, Supernumerary | 1 | 2001 | 1 | 0.010 |
Why?
| | Pigmentation | 1 | 2002 | 52 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2001 | 11 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 121 | 0.010 |
Why?
| | Toothache | 1 | 2001 | 5 | 0.010 |
Why?
| | Flatfoot | 1 | 2001 | 12 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 815 | 0.010 |
Why?
| | Blood Protein Disorders | 1 | 2001 | 1 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 545 | 0.010 |
Why?
| | Periapical Abscess | 1 | 2001 | 3 | 0.010 |
Why?
| | Anti-Retroviral Agents | 1 | 2003 | 231 | 0.010 |
Why?
| | Erbium | 1 | 2001 | 5 | 0.010 |
Why?
| | Yttrium | 1 | 2001 | 5 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 2001 | 12 | 0.010 |
Why?
| | Washington | 1 | 2001 | 148 | 0.010 |
Why?
| | Dentition, Permanent | 1 | 2000 | 4 | 0.010 |
Why?
| | Conjunctivitis | 1 | 2001 | 30 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 1017 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2001 | 141 | 0.010 |
Why?
| | Hemodynamics | 1 | 1985 | 1090 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 486 | 0.010 |
Why?
| | Cesarean Section | 1 | 2001 | 181 | 0.010 |
Why?
| | Mice | 3 | 2004 | 16905 | 0.010 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 10 | 0.010 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 1999 | 15 | 0.010 |
Why?
| | Trans-Activators | 1 | 2001 | 389 | 0.010 |
Why?
| | Scoliosis | 1 | 2001 | 197 | 0.010 |
Why?
| | Dentin Sensitivity | 1 | 1998 | 2 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2000 | 172 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 848 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 18 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 151 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 171 | 0.010 |
Why?
| | Hematoxylin | 1 | 1998 | 5 | 0.010 |
Why?
| | Eosine Yellowish-(YS) | 1 | 1998 | 9 | 0.010 |
Why?
| | Methenamine | 1 | 1998 | 4 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1998 | 115 | 0.010 |
Why?
| | Hearing Loss | 1 | 2001 | 210 | 0.010 |
Why?
| | Logistic Models | 1 | 2003 | 1982 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1998 | 256 | 0.010 |
Why?
| | Point Mutation | 1 | 1999 | 224 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 69 | 0.010 |
Why?
| | Paraffin Embedding | 1 | 1998 | 29 | 0.010 |
Why?
| | Random Allocation | 1 | 1998 | 346 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1416 | 0.010 |
Why?
| | Organic Chemicals | 1 | 1998 | 123 | 0.010 |
Why?
| | Mothers | 1 | 2003 | 730 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1998 | 285 | 0.010 |
Why?
| | Causalgia | 1 | 1996 | 1 | 0.010 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1997 | 35 | 0.010 |
Why?
| | Macrophages | 1 | 2004 | 1481 | 0.010 |
Why?
| | Periodontal Ligament | 1 | 1996 | 3 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1996 | 15 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1996 | 23 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 943 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1998 | 514 | 0.010 |
Why?
| | Substance Abuse, Intravenous | 1 | 1998 | 108 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1998 | 470 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 93 | 0.010 |
Why?
| | Syndrome | 1 | 1996 | 339 | 0.010 |
Why?
| | Digestive System Surgical Procedures | 1 | 1996 | 96 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 510 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2536 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 1995 | 4 | 0.010 |
Why?
| | Phylogeny | 1 | 1999 | 850 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 96 | 0.010 |
Why?
| | Denture, Partial | 1 | 1994 | 2 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1995 | 31 | 0.010 |
Why?
| | Dental Prosthesis | 1 | 1994 | 2 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1613 | 0.010 |
Why?
| | Vincristine | 1 | 1995 | 108 | 0.010 |
Why?
| | Histological Techniques | 1 | 1994 | 40 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1445 | 0.010 |
Why?
| | Patch Tests | 1 | 1994 | 56 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 5438 | 0.010 |
Why?
| | Aneuploidy | 1 | 1994 | 92 | 0.010 |
Why?
| | Homosexuality | 1 | 1993 | 16 | 0.010 |
Why?
| | HIV Core Protein p24 | 1 | 1993 | 31 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2735 | 0.010 |
Why?
| | Ki-1 Antigen | 1 | 1993 | 4 | 0.010 |
Why?
| | Bleomycin | 1 | 1995 | 242 | 0.010 |
Why?
| | Gold | 1 | 1994 | 118 | 0.010 |
Why?
| | Mucins | 1 | 1993 | 70 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1993 | 137 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2146 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1998 | 1336 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 326 | 0.010 |
Why?
| | Cell Cycle | 1 | 1995 | 588 | 0.010 |
Why?
| | Phagocytosis | 1 | 1993 | 362 | 0.010 |
Why?
| | Cell Survival | 1 | 1993 | 1074 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 6392 | 0.000 |
Why?
| | Disease Models, Animal | 1 | 1998 | 4056 | 0.000 |
Why?
| | Saccharin | 1 | 1988 | 6 | 0.000 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 5382 | 0.000 |
Why?
| | Tablets | 1 | 1988 | 35 | 0.000 |
Why?
| | DNA | 1 | 1994 | 1396 | 0.000 |
Why?
| | Theophylline | 1 | 1988 | 68 | 0.000 |
Why?
| | Solutions | 1 | 1988 | 150 | 0.000 |
Why?
| | Sucrose | 1 | 1988 | 99 | 0.000 |
Why?
| | Neutrophils | 1 | 1993 | 1207 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2511 | 0.000 |
Why?
| | Anticonvulsants | 1 | 1988 | 209 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1988 | 1702 | 0.000 |
Why?
|
|
Flaitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|